Hepatitis B Reactivation and Pregnancy
On this page
Direct answer
Hepatitis B reactivation is the return of hepatitis B virus replication in someone with past infection, most often after immunosuppression. Patients who are HBsAg positive carry the highest risk, while HBsAg-negative, anti-HBc-positive patients are at risk mainly with rituximab or high-dose steroids. In pregnancy the central goal is preventing mother-to-child transmission, which combines tenofovir for high viral load with hepatitis B immunoglobulin and vaccination of the newborn.
What you must remember
- Highest-risk group: HBsAg-positive patients, who need antiviral prophylaxis before chemotherapy or immunosuppression.
- Anti-HBc-positive, HBsAg-negative: at risk mainly with rituximab or high-dose steroids, and prophylaxis (or close monitoring of HBV DNA and ALT) is chosen by the regimen's risk.
- Prophylactic agents: entecavir or tenofovir, continued for a defined period after the last dose of immunosuppression.
- Reactivation course: a hepatitis flare that can be severe, sometimes fulminant, so ALT and HBV DNA are monitored.
- Pregnancy antiviral: tenofovir disoproxil fumarate for high viral load, started in the late second or third trimester.
- Newborn protection: hepatitis B immunoglobulin and the first vaccine dose within 12 hours of birth, then the full series.
- Birth dose in India: hepatitis B birth dose is part of the Universal Immunization Programme.
A pathway for an HBsAg-positive pregnant woman
A 27-year-old woman at 30 weeks of pregnancy is HBsAg positive with a high HBV DNA. The examiner asks which drug to start and how to protect the baby.
- Measure the viral load: HBV DNA above a threshold of around 200,000 IU/mL, per current guidance, signals a higher risk of transmission.
- Start tenofovir when indicated: Tenofovir disoproxil fumarate is started in the late second or third trimester for women with high viral load, and it is generally considered acceptable in pregnancy.
- Continue antiviral therapy after delivery: If treatment was only for prevention, it may be stopped at delivery or up to about 12 weeks postpartum, and ALT and HBV DNA are monitored for a postpartum flare.
- Give immunoglobulin and vaccine at birth: Hepatitis B immunoglobulin and the first vaccine dose are given within 12 hours of birth, followed by the complete series.
- Test the infant after the series: Anti-HBs and HBsAg testing after completion confirm protection and exclude infection.
- Counsel on breastfeeding: Breastfeeding is generally allowed on tenofovir when the infant has received immunoglobulin and vaccine at birth.
Where the exam tests the reactivation trap
Hepatitis B questions reward attention to the timing of drugs and doses rather than to the diagnosis alone.
- Trap: using HBsAg-negative status to exclude reactivation risk Correct: anti-HBc positivity alone places the patient at risk during rituximab or high-dose steroid therapy.
- Trap: ignoring the mother after delivery Correct: postpartum flares are recognised, so ALT and HBV DNA are monitored for months after tenofovir is stopped.
- Trap: delaying the birth dose because the infant will be breastfed Correct: immunoglobulin and vaccine are given within 12 hours of birth regardless of feeding method.
Frequently asked questions
Which patients are at highest risk of hepatitis B reactivation?
Patients who are HBsAg positive are at highest risk, while HBsAg-negative, anti-HBc-positive patients are at risk mainly with rituximab or high-dose steroids. Prophylaxis with an antiviral such as entecavir or tenofovir is started before immunosuppression in the highest-risk groups, with monitoring as an option in lower-risk regimens.
Why is tenofovir used in pregnant women with hepatitis B?
Tenofovir disoproxil fumarate is used in pregnant women with high viral load to reduce mother-to-child transmission. It is started in the late second or third trimester and is generally considered acceptable in pregnancy, while the infant still receives immunoglobulin and vaccination at birth.
What must be given to a newborn of an HBsAg-positive mother?
A newborn of an HBsAg-positive mother should receive hepatitis B immunoglobulin and the first vaccine dose within 12 hours of birth, followed by the complete vaccine series. This combined approach prevents most perinatal transmission, even when the mother is on antiviral therapy.
Can a mother with hepatitis B breastfeed her baby?
Breastfeeding is generally allowed for women with hepatitis B, including those on tenofovir, provided the newborn has received immunoglobulin and vaccine at birth. Cracked or bleeding nipples are a relative caution, so the advice should be individualised.